Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR098867A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 22-11-2016
Patent type: Dosages

Click within the document, or manually enter the page number below

CILFA opposition, Navafenterol sacchrinate in combination with corticosteroids, (AR097078A1)

Countries: Argentina Date: 2016
CILFA opposition, cetirizine, (P990104039)

Countries: Argentina Date: 2002
CILFA opposition, neurokinin antagonist/H1 antagonist/H2 antagonists, (P990105080)

Countries: Argentina Date: 2002
CILFA opposition, Salmeterol, (AR100687A1)

Countries: Argentina Date: 2017
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)

Countries: Argentina Date: 2016
CILFA opposition, MELOXICAM, (AR100293A2)

Countries: Argentina Date: 2016
CILFA opposition, Aclidinium, (AR095705A1)

Countries: Argentina Date: 2016
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)

Countries: Argentina Date: 2016
CILFA opposition, aripiprazole, (AR098808A2)

Countries: Argentina Date: 2016
CILFA opposition, Atazanavir / cobicistat, (AR099119A1)

Countries: Argentina Date: 2016

Cilfa Opposition, Salmeterol, (Ar098867 A1)